ENDRA LIFE SCIENCES INC. Debt Conversion, Converted Instrument, Amount
ENDRA LIFE SCIENCES INC. (NDRA) reported Debt Conversion, Converted Instrument, Amount of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2022-03-30
- ENDRA LIFE SCIENCES INC. debt conversion, converted instrument, amount for the quarter ending 2021-12-31 was $0.00.
- ENDRA LIFE SCIENCES INC. debt conversion, converted instrument, amount for the quarter ending 2021-09-30 was $0.00.
- ENDRA LIFE SCIENCES INC. debt conversion, converted instrument, amount for the quarter ending 2021-06-30 was $0.00.
- ENDRA LIFE SCIENCES INC. debt conversion, converted instrument, amount for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- ENDRA LIFE SCIENCES INC. debt conversion, converted instrument, amount for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- ENDRA LIFE SCIENCES INC. debt conversion, converted instrument, amount for fiscal 2020 was $493.81K.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $0.00 derived: sum of 2 quarters · filed 2022-03-30 | $0.00 derived: sum of 3 quarters · filed 2022-03-30 | $0.00 10-K · filed 2022-03-30 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | $0.00 derived: sum of 4 quarters · filed 2022-03-30 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 | $0.00 derived: sum of 3 quarters · filed 2022-03-30 | $0.00 derived: sum of 4 quarters · filed 2022-03-30 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-17 | $0.00 derived: sum of 2 quarters · filed 2022-03-30 | $0.00 derived: sum of 3 quarters · filed 2022-03-30 | $0.00 derived: sum of 4 quarters · filed 2022-03-30 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $0.00 derived: sum of 2 quarters · filed 2022-03-30 | $0.00 derived: sum of 3 quarters · filed 2022-03-30 | $493.81K 10-K · filed 2022-03-30 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $493.81K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $493.81K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $493.81K 10-Q · filed 2021-05-17 | |||
| 2019-09-30 | $140.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $140.41K derived: sum of 2 quarters · filed 2020-11-16 | $140.41K 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $0.00 10-Q · filed 2020-08-14 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-14 | |||
| 2018-09-30 | $50.00K 10-Q · filed 2018-11-05 | |||
| 2017-09-30 | $1.73M 10-Q · filed 2018-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |